Departments of Pathology, Urology, and Internal Medicine, University of Michigan, Ann Arbor, Michigan; Department of Cell Biology, Baylor College of Medicine, Houston, Texas; Departments of Oncology and Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; and Na...

1Division of Hematology-Oncology, Children’s Hospital Boston, Boston, MA; 2Dana-Farber Cancer Institute, Boston, MA; 3Harvard Medical School, Boston, MA; 4Harvard Stem Cell Institute, Boston, MA; 5Department of Cell and Regenerative Biology, Paul Carbone Comprehensive Cancer Center, Wisconsin Institutes for Medical Research, University of Wisconsin School of Medicine and Public Health, Madison,...

'Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 2Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts; 3Department of Genitourinary Oncology, Dana Farber Cancer Institute, Boston, Massachusetts; 4Department of Health Policy and Management, Harvard School of Public Health, Boston, Mas...

1Translational Medicine Division, Brigham and Women’s Hospital, Boston, MA; 2Vascular Biology Program, Department of Surgery, Children’s Hospital, Boston, MA; 3Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA; 4Laboratory for Pediatric Molecular Biology, Charité Medical University, Berlin, Germany; 5Department of Cell Biology and Genetics, Erasmu...

Affiliations of authors: Internal Medicine and Pharmacology, University of Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BLJ); Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (MR); Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX...

1Department of Pediatric Oncology, 2Center for Outcomes and Policy Research, and 3Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA; 4Department of Medicine, Children’s Hospital Boston, MA; 5Department of Pediatrics, Peyton Manning Children’s Hospital at St Vincent, Indianapolis, IN; and 6Department of Pediatric Hematology-Oncology, Children’s Hos...

1Vascular Biology Program, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115, USA 2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA 3Department of Biochemistry & Molecular Biology, University of Calgary, Calgary, AB, Canada T2N 4N1 4 Institute for Biocomplexity and Informatics, University of Calgary, Calgary, AB, Ca...

1Harvard Medical School, Boston, MA; 2Harvard Stem Cell Institute, Boston, MA; 3Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA; 4Department of Laboratory Medicine, Joint Program in Transfusion Medicine, Children’s Hospital, Boston, MA; 5Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; and 6Cancer Science Instit...

1 Department of Psychology and Neuroscience, Duke University, Durham, North Carolina, United States of America, 2 Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America, 3 Department of Society, Human Development & Health, Harvard School of Public Health, Boston, Massachusetts, United States of America, 4 Center for Community-Based Research, Dana Farber ...

1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; 2Institute of Hematology, University of Perugia, Perugia, Italy; 3Institute of Cancer, Barts and the London School of Medicine, London, United Kingdom; 4Karlsruhe Institute of Technology, Forschungszentrum Karlsruhe, Karlsruhe, Germany; and 5Division of Hematology/Oncology, Department of Pediatr...